Company / Current Liabilities
Kura Oncology, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$117.0M
FY2025
5-year range
$22.5M / $117.0M
FY2021-FY2025
Trend
+48.6%
vs FY2024
Sector context
#89 of 213
Health Care
What the data says
At $117M, Kura Oncology, Inc.'s current liabilities ranks #125 of 213 in the Health Care sector. Current Liabilities has increased for 4 consecutive years, from $22M in FY2021 to $117M in FY2025.
Based on SEC 10-K filings.
$117M in FY2025 with a 5-year CAGR of +35.1%.
Increased from $35M to $117M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +69.4%
- 5-Year CAGR
- +35.1%
- 10-Year CAGR
- -
Sector benchmark
#125 of 213 in Health CareTop 58% of 213This company $117.0M Sector average $1.6B
▼
-92.6% below sector average
Key checks
Key Insights
- Kura Oncology, Inc.'s current liabilities has grown for 4 consecutive years.
- 5-year CAGR of +35.1%, indicating consistent growth.
- In FY2025, current liabilities increased 48.6% year-over-year.
- Ranks #89 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $117.0M | +48.6% |
| FY2024 | $78.7M | +123.2% |
| FY2023 | $35.3M | +46.6% |
| FY2022 | $24.1M | +7.1% |
| FY2021 | $22.5M | -13.7% |
| FY2020 | $26.0M | +67.2% |
| FY2019 | $15.6M | +14.3% |
| FY2018 | $13.6M | +35.7% |
| FY2017 | $10.0M | +84.0% |
| FY2016 | $5.5M | +7.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026